the aid library

LIST OPTIONS

Filter

7706

Good practice statement on the use of variant-containing COVID-19 vaccines

World Health Organization WHO (2022) C_WHO

Declarations of interests were collected from all external contributors and assessed for any conflicts of interest. Summaries of the reported interests can be found on the SAGE meeting website and SAGE Covid-19 Working Group webpage. This guidance should be considered along with the broader COVID-... more

Download (363)

View PDF (366)

ICO Guidelines for Diabetic Eye Care

Interntaional Council of Opthalmology ICO (2017) C1

Updated 2017

Download (292)

View PDF (483)

Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy

World Health Organization WHO (2013) C_WHO

New criteria for classifying and diagnosing hyperglycaemia first detected during pregnancy have been accepted by a group of experts convened by WHO. These new criteria are an update of recommendations published by WHO in 1999

Download (191)

View PDF (209)

Solidarity - Country Spotlight Democratic Republic of Congo

Catholic Relief Services CRS (2015) C1

Lesson Plans grades 1–8

Download (806)

View PDF (1337)

Zika Virus Research Agenda - October 2016

World Health Organization WHO (2016) C_WHO

Download (151)

View PDF (200)

Indoor air quality at home

National Institute for Health and Care Excellence (NICE) (2020) C2

This guideline covers indoor air quality in residential buildings. It aims to raise awareness of the importance of good air quality in people's homes and how to achieve this.

Download (323)

View PDF (554)

Mental health problems in people with learning disabilities

National Institute for Health and Care Expericen (NICE) (2016) C1

Prevention, Assessment and Management

Download (265)

View PDF (109)

Hypertension in adults: diagnosis and management

the National Institute for Health and Care Excellence (NICE) the National Institute for Health and Care Excellence (NICE) (2023) CC

The NICE guideline "Hypertension in Adults: Diagnosis and Management" outlines recommendations for diagnosing and managing hypertension in adults over 18, including those with type 2 diabetes. It emphasizes accurate blood pressure measurement, recommending ambulatory or home monitoring to confirm di... more

External Link

Protection Against Sexual Exploitation and Abuse, Multi-Year Strategy for Ukraine 2023-25
recommended

UN Country Team in Ukraine (2023) CC

The purpose of this multi-year strategy is to guide the strategic direction for the collective work of the Protection against Sexual Exploitation and Abuse (PSEA) Programme in Ukraine. It replaces the 2017 HCT Framework on PSEA in Ukraine, incorporates the priorities set by the IASC Vision and Strat... more

Download (323)

View PDF (543)

Manual on Flood: Causes, Effects & Preparedness

The Republic of the Union of Myanmar, Relief and Resettlement Department; UN-Habitat (2010) C1

No publication year indicated.

Download (97)

View PDF (106)

Type 2 diabetes in adults: management

National Institute for Communicable Disease (NICE) National Institute for Communicable Disease (NICE) (2022) CC2

This guideline covers care and management for adults (aged 18 and over) with type 2 diabetes. It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications.

Download (236)

View PDF (222)

Learning Modules. COVID-19 Vaccines in Pregnancy and Safe Breastfeeding

Pan American Health Organization (PAHO) (2023) C_WHO

This is an e-learning module with the objective of providing education for health professionals and pregnant women using published results and studies based on COVID-19 surveillance data, which have indicated an increased risk among pregnant women of presenting with severe forms of COVID-19 and, the... more

Download (172)

View PDF (209)

Interim recommendations for heterologous COVID-19 vaccine schedules

World Health Organization WHO (2021) C_WHO

Overview 16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).

Download (345)

View PDF (456)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (1026)

View PDF (1330)

Tips for Lowering pharmacy Temperatures To maintain good medicine Quality

USAID, SIAPS (2014) CC

Accessed July 2014

Download (172)

View PDF (174)

RMRP 2020 - Regional Refugee and Migrant Response Plan for Refugees and Migrants from Venezuela 2020

R4V; reliefweb (2020) C2

The Venezuelan refugee and migrant crisis is one of the biggest external displacement crises in the world today. The COVID-19 pandemic has compounded an already desperate situation for many refugees and migrants, as well as their hosts, sorely testing health and social welfare systems and the abilit... more

Download (337)

View PDF (768)

Myanmar refugee emergency response in Bangladesh: Supplementary appeal March - December 2018

UN High Commissioner for Refugees (2018) C1

External Link

MSF: Psychosocial and Mental Health Interventions in Areas of Mass Violence
recommended

Kaz de Jong Médecins Sans Frontières (2011) C2

A community-based approach. These guidelines focus on manmade rather than natural disasters, but our experiences in India, El Salvador and Pakistan (earthquake interventions), and following the 2004 tsunami, cyclone Nargis in 2008 and the Haiti earthquake in 2010, showed that the principles describ... more

Download (161)

View PDF (187)

Fair allocation mechanism for COVID-19 vaccines through the COVAX Facility

World Health Organization WHO (2020) C_WHO

9 September 2020 In a snapshot, fair allocation of vaccines will occur in the following way: An initial proportional allocation of doses to countries until all countries reach enough quantities to cover 20% of their population This document is also available in Arabic | Chinese | French | R... more

Download (1563)

View PDF (2335)

community-based rehabilitation: CBR guidelines - Education component

Kamala Achu, Kathy Al Jubah, Svein Brodtkorb, et al. WHO (2010) C_WHO

Available in: English, French, Chinese, Spanish, Russian, Arabic, Thai, Korean, Tajik, Vietnamese, Uzbek http://www.who.int/disabilities/cbr/guidelines/en/

Protection Against Sexual Exploitation and Abuse, Multi-Year Strategy for Ukraine 2023-25 recommended

MSF: Psychosocial and Mental Health Interventions in Areas of Mass Violence recommended

Protection Against Sexual Exploitation and Abuse, Multi-Year Strategy for Ukraine 2023-25
recommended

MSF: Psychosocial and Mental Health Interventions in Areas of Mass Violence
recommended